ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)

SHA:600479 Revenue

In the year 2025, ZhuZhou QianJin Pharmaceutical Co.,Ltd had annual revenue of 3.63B CNY, down -0.03%. ZhuZhou QianJin Pharmaceutical Co.,Ltd had revenue of 910.51M in the quarter ending December 31, 2025, a decrease of -0.51%.

• Revenue: 3.63B
• Revenue Growth: -0.03%
• P/S Ratio: 1.50
• Revenue / Employee: 688.59K
• Employees: 5,270
• Market Cap: 5.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.63B	-961.39K	-0.03%
Dec 31, 2024	3.63B	-168.68M	-4.44%
Dec 31, 2023	3.80B	-227.79M	-5.66%
Dec 31, 2022	4.03B	362.43M	9.89%
Dec 31, 2021	3.66B	36.88M	1.02%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error